Terry Fortin

4.1k total citations · 2 hit papers
17 papers, 2.9k citations indexed

About

Terry Fortin is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Terry Fortin has authored 17 papers receiving a total of 2.9k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 10 papers in Pulmonary and Respiratory Medicine and 3 papers in Surgery. Recurrent topics in Terry Fortin's work include Pulmonary Hypertension Research and Treatments (10 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Liver Disease and Transplantation (3 papers). Terry Fortin is often cited by papers focused on Pulmonary Hypertension Research and Treatments (10 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Liver Disease and Transplantation (3 papers). Terry Fortin collaborates with scholars based in United States, Switzerland and Denmark. Terry Fortin's co-authors include Douglas C McCrory, Carolyn H. McCabe, James T. Dodge, Barbara T. Alexander, Eugene Braunwald, C. Michael Gibson, Christopher P. Cannon, William Daley, W. Kenneth Poole and Susan J. Marble and has published in prestigious journals such as Circulation, SHILAP Revista de lepidopterología and Journal of the American College of Cardiology.

In The Last Decade

Terry Fortin

14 papers receiving 2.8k citations

Hit Papers

TIMI Frame Count 1996 2026 2006 2016 1996 2004 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. TIMI Frame Count
    1996 1.5k citations C. Michael Gibson, Christopher P. Cannon et al. Circulation profile →
  2. Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension
    2004 676 citations Michael D. McGoon, David D. Gutterman et al. CHEST Journal profile →

Peers

Terry Fortin
Peter M. Steele Australia
Laura Scelsi Italy
Myung H. Park United States
Khaled M. Ziada United States
Roberto Badagliacca Italy
Morgan Fu Taiwan
Nirat Beohar United States
Massimiliano Palazzini Italy
Nowell M. Fine Canada
Masahiko Ochiai Japan
Peter M. Steele Australia
Terry Fortin
Citations per year, relative to Terry Fortin Terry Fortin (= 1×) peers Peter M. Steele

Countries citing papers authored by Terry Fortin

Since Specialization
Citations

This map shows the geographic impact of Terry Fortin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Terry Fortin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Terry Fortin more than expected).

Fields of papers citing papers by Terry Fortin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Terry Fortin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Terry Fortin. The network helps show where Terry Fortin may publish in the future.

Co-authorship network of co-authors of Terry Fortin

This figure shows the co-authorship network connecting the top 25 collaborators of Terry Fortin. A scholar is included among the top collaborators of Terry Fortin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Terry Fortin. Terry Fortin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Swaminathan, Aparna, Alice Parish, Cynthia L. Green, et al.. (2024). Evaluation of patients with severe pulmonary hypertension and a range of comorbidities prescribed inhaled treprostinil. SHILAP Revista de lepidopterología. 6. 100131–100131.
2.
Beckman, Joshua A., et al.. (2023). Utility of electrocardiographic findings in acute pulmonary embolism. European Heart Journal Open. 3(6). oead121–oead121. 1 indexed citations
3.
Swaminathan, Aparna, Alice Parish, Cindy Green, et al.. (2021). OUTCOMES OF PATIENTS ACROSS THE SPECTRUM OF PULMONARY HYPERTENSION GROUPS PRESCRIBED INHALED TREPROSTINIL. CHEST Journal. 160(4). A2250–A2251.
4.
Barbas, Andrew S., Jacob N. Schroder, Arturo Suarez, et al.. (2020). Planned Initiation of Venoarterial Extracorporeal Membrane Oxygenation Prior to Liver Transplantation in a Patient With Severe Portopulmonary Hypertension. Liver Transplantation. 27(5). 760–762. 17 indexed citations
5.
Patel, Manesh R., et al.. (2020). ELECTROCARDIOGRAPHIC CHARACTERISTICS IN A LARGE COHORT OF ACUTE PULMONARY EMBOLISM. Journal of the American College of Cardiology. 75(11). 2272–2272.
6.
Swaminathan, Aparna, Hongmei Zhu, Victor F. Tapson, et al.. (2020). Treatment-related biomarkers in pulmonary hypertension patients on oral therapies. Respiratory Research. 21(1). 304–304. 4 indexed citations
7.
Parikh, Kishan S., et al.. (2020). Experience in Transitioning From Parenteral Prostacyclins to Selexipag in Pulmonary Arterial Hypertension. Journal of Cardiovascular Pharmacology. 75(4). 299–304. 11 indexed citations
8.
Parikh, Kishan S., Talal Dahhan, Nicole F. Ruopp, et al.. (2019). Clinical Features and Outcomes of Patients with Sarcoidosis-associated Pulmonary Hypertension. Scientific Reports. 9(1). 4061–4061. 33 indexed citations
9.
Frost, Adaani, Munir Janmohamed, Jason S. Fritz, et al.. (2018). Safety and tolerability of transition from inhaled treprostinil to oral selexipag in pulmonary arterial hypertension: Results from the TRANSIT-1 study. The Journal of Heart and Lung Transplantation. 38(1). 43–50. 27 indexed citations
10.
Parikh, Kishan S., Sudarshan Rajagopal, Terry Fortin, Victor F. Tapson, & Abby Poms. (2016). Safety and Tolerability of High-dose Inhaled Treprostinil in Pulmonary Hypertension. Journal of Cardiovascular Pharmacology. 67(4). 322–325. 12 indexed citations
11.
Rajagopal, Sudarshan, Daniel Forsha, Niels Risum, et al.. (2014). Comprehensive Assessment of Right Ventricular Function in Patients with Pulmonary Hypertension with Global Longitudinal Peak Systolic Strain Derived from Multiple Right Ventricular Views. Journal of the American Society of Echocardiography. 27(6). 657–665.e3. 67 indexed citations
12.
Meine, Trip J., Manesh R. Patel, John F. Heitner, et al.. (2005). Cardiac Imaging Impaired by a Silicone Breast Implant. Clinical Nuclear Medicine. 30(4). 262–264. 5 indexed citations
13.
McLaughlin, Vallerie V., Kenneth W. Presberg, Ramona L. Doyle, et al.. (2004). Prognosis of Pulmonary Arterial Hypertension*. CHEST Journal. 126(1). 78S–92S. 403 indexed citations
14.
McGoon, Michael D., David D. Gutterman, Virginia Steen, et al.. (2004). Screening, Early Detection, and Diagnosis of Pulmonary Arterial Hypertension. CHEST Journal. 126(1). 14S–34S. 676 indexed citations breakdown →
15.
Gibson, C. Michael, Christopher P. Cannon, William Daley, et al.. (1996). TIMI Frame Count. Circulation. 93(5). 879–888. 1499 indexed citations breakdown →
16.
Strauss, William, Terry Fortin, Pamela Hartigan, Edward D. Folland, & Alfred F. Parisi. (1995). A Comparison of Quality of Life Scores in Patients With Angina Pectoris After Angioplasty Compared With After Medical Therapy. Circulation. 92(7). 1710–1719. 79 indexed citations
17.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Peter M. Steele Breakdown of academic impact, for papers by Laura Scelsi Breakdown of academic impact, for papers by Myung H. Park Breakdown of academic impact, for papers by Khaled M. Ziada Breakdown of academic impact, for papers by Roberto Badagliacca Breakdown of academic impact, for papers by Morgan Fu Breakdown of academic impact, for papers by Nirat Beohar Breakdown of academic impact, for papers by Massimiliano Palazzini Breakdown of academic impact, for papers by Nowell M. Fine Breakdown of academic impact, for papers by Masahiko Ochiai
Rankless by CCL
2026